Heterozygous Beta‐Thalassaemia in Pregnancy: Two Rare Causes of Severe Fetal Anemia Requiring Intrauterine Blood Transfusions
Eva van der Meij,Frans J. W. Smiers,Tamara T. Koopmann,Ingrid Krapels,Kaatje LePoole,Enrico Lopriore,Johanna M. Middeldorp,Claudia S. Ootjers,Volkher Scharnhorst,Hubertina C. J. Scheepers,Cornelis L. Harteveld,E. J. T. (Joanne) Verweij
DOI: https://doi.org/10.1002/pd.6695
2024-11-04
Prenatal Diagnosis
Abstract:Aim In this article, we present two cases of severe fetal hemolytic anemia based on a beta‐thalassaemia trait inherited from a single parent. Results These cases, presented at 20 and 28 weeks' gestation, necessitated intra‐uterine blood transfusions. This occurrence is remarkable because it challenges the common assumption that beta‐thalassaemia typically has no prenatal implications regarding fetal anemia. Both fetuses inherited a rare heterozygous mutation from their mother, resulting in gamma‐thalassaemia‐related anemia. In the first case, the anemia was related to a deletion in the beta locus control region (βLCR) and in the second case, a deletion on chromosome 11p15.4 was the cause. These mutations not only affect the beta chain production, but also the gamma chain production, leading to a reduction in the synthesis of HbF, ineffective erythropoiesis and consequently, perinatal hemolytic anemia. Conclusion Clinicians should be vigilant regarding these rare mutations in families with a history of beta‐thalassaemia as the fetal clinical consequences can be severe and intra‐uterine blood transfusions may prove life‐saving for these fetuses.
genetics & heredity,obstetrics & gynecology